iconiifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Apollo Hospitals Q3 net up 75.1% yoy at Rs228.37cr on smart top line boost and cost efficiencies

12 Feb 2022 , 11:35 AM

Apollo Hospitals Enterprise
Apollo Hospitals reported 31.85% yoy growth in total sales revenues for the Dec-21 quarter on consolidated basis at Rs3,639cr. On a sequential basis, the revenues were marginally lower by -2.10%.

During the December 2021 quarter, revenues from the core healthcare services business saw an increase of 40.3% at Rs2,024cr. The pharmacy distribution vertical saw revenues grow yoy by 16% at Rs1,307cr.

The clinics verticals also saw growth of 59% yoy at Rs313cr. The retail pharmacy business has already been transferred to Apollo Pharmacy. During the quarter, the company raised Rs1,170cr via a QIP placement of 46.6 lakh shares at a price of Rs2,511.

For the Dec-21 quarter, the operating profits were up 65.14% at Rs438.03cr. However, on a sequential basis, the operating profits were lower by -6.85%.

In terms of the operating performance of various verticals, the principal healthcare services vertical saw operating profits grow by 102% you at Rs382cr. The clinics vertical was the surprise package with operating profits in the quarter growing by nearly 4-fold at Rs25cr while the pharmacy distribution business saw operating profits fall sharply by -55% at Rs32.1cr on a yoy basis.

The cost of materials and consumables were up 35% yoy but was offset by inventory efficiency gains in the quarter. Operating margins improved from 9.61% in Dec-20 quarter to 12.04% in the Dec-21 quarter. However, the operating margins were about 61 bps lower on a sequential basis.

Net Profit after tax (PAT) for the Dec-21 quarter was up 75.09% yoy at Rs228.37cr as the strong operating performance in the quarter got transmitted to the bottom line. Other Expenses escalated sharply in the quarter .

PAT margins improved from 4.73% in the Dec-20 quarter to 6.28% in the Dec-21 quarter. The PAT margins were lower by 49 bps on a sequential basis.

Financial highlights for Dec-21 compared yoy and sequentially

Apollo Hospitals
Rs in Crore Dec-21 Dec-20 YOY Sep-21 QOQ
Total Income (Rs cr) ₹ 3,638.93 ₹ 2,759.85 31.85% ₹ 3,717.07 -2.10%
Operating Profit (Rs cr) ₹ 438.03 ₹ 265.25 65.14% ₹ 470.24 -6.85%
Net Profit (Rs cr) ₹ 228.37 ₹ 130.43 75.09% ₹ 247.82 -7.85%
Diluted EPS (Rs) ₹ 15.88 ₹ 9.38 ₹ 17.24
Operating Margins 12.04% 9.61% 12.65%
Net Margins 6.28% 4.73% 6.67%

Related Tags

  • Apollo Hospitals management
  • Apollo Hospitals news
  • Apollo Hospitals Q3
  • Apollo Hospitals Q3FY22 Healthcare Business
  • Apollo Hospitals Q3FY22 PAT
  • Apollo Hospitals Q3FY22 Result
  • Apollo Hospitals quarterly results
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

4 Mar 2024   |   09:10 AM
4 Mar 2024   |   08:43 AM
4 Mar 2024   |   08:40 AM
3 Mar 2024   |   12:26 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.